Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Cancers|August 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse ModelMari I Suominen, Matias Knuuttila, Birgitta Sjöholm, et al.Gastroenterology|September 2, 2003
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancerArne Scholz, Sandra Heinze, Katharina M Detjen, et al.Journal of Hepatology|August 29, 2006
Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinomaMeike Körner, Gregory M Hayes, Ruth Rehmann, et al.Journal of the National Cancer Institute|March 20, 2003
Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesisZofia von Marschall, Arne Scholz, Thorsten Cramer, et al.International Journal of Cancer|March 15, 2008
VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinomaArmin Thelen, Arne Scholz, Christoph Benckert, et al.Annals of Surgical Oncology|February 19, 2009
Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinomaArmin Thelen, Sven Jonas, Christoph Benckert, et al.Neoplasia (New York, N.Y.)|November 9, 2013
Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinomaRoberta Schmieder, Florian Puehler, Roland Neuhaus, et al.Bioorganic & Medicinal Chemistry Letters|November 28, 2015
Optimization of allosteric MEK inhibitors. Part 2: Taming the sulfamide group balances compound distribution propertiesIngo V Hartung, Stefanie Hammer, Marion Hitchcock, et al.International Journal of Oncology|February 13, 2019
Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinomaHung Huynh, Richard Ong, Kah Yong Goh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Angiopoietin-2 promotes disease progression of neuroendocrine tumorsKatharina M Detjen, Svenja Rieke, Antje Deters, et al.Pageof 5